Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-25-000860
Filing Date
2025-08-04
Accepted
2025-08-04 16:52:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9585
  Complete submission text file 0000899140-25-000860.txt   11404
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-87833 | Film No.: 251181184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 888 7TH AVENUE, 41ST FLOOR NEW YORK NY 10019
Business Address 888 7TH AVENUE, 41ST FLOOR NEW YORK NY 10019 212-299-4785
Hein Park Capital Management LP (Filed by) CIK: 0001826937 (see all company filings)

EIN.: 842820894 | State of Incorp.: DE
Type: SCHEDULE 13D/A